Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$1.03
+7.54%
Mkt Cap $16.51M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$8.75
Range $3.00 – $13.00
Implied Upside
+749.5%
Consensus $8.75 vs current $1.03
NASDAQ·Healthcare·Biotechnology
$1.03
+7.54%
Mkt Cap $16.51M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$8.75
Range $3.00 – $13.00
+749.5%
Consensus $8.75 vs current $1.03